Welcome to OM Pharma
Immunostimulant - Immunotherapy
Uro Vaxom® : Urinary tract infection - UTI - Cystitis
  Philosophy
  History
  Worldwide activity
  R & D
  Manufacturing
  Products
    Marketing Authorizations
    International Availability
  Main Products
    - Broncho-Vaxom
    - Dicynone
    - Doxium
    - Uro-Vaxom
    Other Products
    - Doxiproct
    - Doxiproct Plus
    - Gynazole
    - Sinomarin
  Health and Diseases
  News
  Contacts
  Careers and jobs
  Forum


  homepage > productsuro-vaxom > limitations for use
   
  Uro-Vaxom
 
Limitations for use

Contraindications
Known hypersensitivity towards the constituents of Uro-Vaxom.

Precautions
The efficacy and safety of Uro-Vaxom have not been established in children below 4 years.

Effects on ability to drive and use machines
Uro-Vaxom is presumed to be safe and unlikely to produce a sedative effect.

Pregnancy and lactation
Reproduction studies in animals have not demonstrated any risk to the fetus, but controlled studies in pregnant women are not available.
As regards breast-feeding, no specific studies have been performed and no data have been reported up to now.
  Contact us   back home